anonymous
Guest
anonymous
Guest
Genentech
At No. 2, Genentech boasted breakthrough research milestones this year in retinal vein occlusion, multiple sclerosis, spinal muscular atrophy, lymphoma and influenza in young children. Genentech has forged successful partnerships as well. In September, BioSpace reported its deal with Arsenal Biosciences, a multi-year collaboration to identify critical success circuits in T cell-based therapies for solid tumors.
and what was this suppose to do?